News

The deal covers about 76,000 ovarian cancer claims and requires acceptance by at least 95% of claimants to take effect

Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming its baby powder and other talcum powder products caused ovarian cancer, the company says.

Target (TGT) is under fresh scrutiny after being named in a lawsuit tied to Nara Organics infant formula that allegedly caused a confirmed case of infant botulism in Washington, which is part of a broader FDA and CDC outbreak investigation. See our latest analysis for Target. The Nara Organics lawsuit lands at a time when Target's share price has a year to date return of 39.63% and a 1 year total shareholder return of 37.63%, while its 5 year total shareholder return is down 36.52%. This...

Johnson & Johnson (J&J) has offered to pay $5.5bn (£4.13bn) to resolve tens of thousands of lawsuits in the US alleging its talcum powder caused ovarian cancer. The company said the settlement covers around 76,000 claims, having already settled most cases alleging its talc contained asbestos and caused mesothelioma. J&J's vice president of litigation, Erik Haas, said the move was motivated by a desire to get closure – describing the claims themselves as "meritless".

In the midst of an expensive AI transformation, the company is grappling with litigation that could cost it billions and force painful changes.

The company said it reached an agreement with firms representing plaintiffs in the outstanding talc cases to pay up to $3 billion in claim payments in 2027, with no further payments due before 2028.

NEW YORK, July 27 (Reuters) - The former JPMorgan Chase banker whose lurid sexual harassment lawsuit went viral added new claims and defendants on Monday, saying the largest U. bank's acceptance of racism and sexual coercion irreparably destroyed his ‌career.

Ford just issued recalls covering nearly a million vehicles, and while that spells trouble for its own shareholders, a handful of publicly traded dealer groups are quietly positioned to profit from every car that rolls into the service bay.

LONDON, July 27 (Reuters) - Elon Musk's Tesla on Monday won its bid to revive a London lawsuit brought against U.S. technology firm InterDigital and a patent licensing platform, seeking a patent

C3.ai, Inc. recently secured a full dismissal of a putative securities class action in the U.S. District Court for the Northern District of California, removing all asserted claims against the company and certain officers. This legal outcome, combined with recent revenue and EPS results that exceeded analyst expectations, reduces uncertainty around C3.ai’s operations and may influence how investors assess its risk profile. We’ll now examine how the full dismissal of the securities lawsuit...

The lawsuit will likely renew debates about whether term employment agreements are enforceable under California. law

Yahoo Finance Senior Reporter Brooke DiPalma explains what you need to know about the recent egg recall, Lamb Weston's (LW) quarterly earnings, and Coors Light's (TAP) partnership with Cheez-It on "beer cheese crackers."

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Tesla (TSLA) will not face a defect investigation over the manual door release on Model 3 vehicles a

Capital One Financial (NYSE:COF) has been named in a major lawsuit tied to alleged fraud involving the Zelle payments network. The company is identified as a co-owner of Zelle in the case, which focuses on consumer losses linked to disputed transactions. Separately, Capital One agreed to a C$35 million settlement in a Canadian class action related to a prior data breach. Capital One Financial, a large US card issuer and bank with a growing digital footprint, now sits at the center of two...

Red Cat Holdings, Inc. previously terminated Chief Revenue Officer Geoffrey Hitchcock for cause, after a board hearing under his executive employment agreement, and informed him he would receive only accrued salary and benefits through his termination date. Following this decision, Hitchcock filed a civil complaint alleging retaliatory termination and contract breaches, creating additional legal and governance questions around Red Cat’s leadership and internal controls. Now we’ll examine how...

R.K.C. had already settled with YouTube, TikTok, and Snap, leaving Meta as the sole defendant ahead of jury selection

The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart health.

Pfizer (PFE) is back in focus after Arbutus Biopharma and Genevant Sciences expanded their patent litigation over mRNA lipid nanoparticle technology, adding new international cases that raise legal and operational questions for the company’s COVID-19 vaccine business. See our latest analysis for Pfizer. The legal headlines around Pfizer’s mRNA vaccine coincide with a mixed price pattern, with the stock showing a 1-day share price return of 0.77% and a 7-day share price return of 2.85%, but a...

A closely watched social media addiction lawsuit that had been set to go to trial next week has been dropped after the plaintiff voluntarily dismissed his claims against Meta, leaving none of the major tech companies facing trial in the case.

A Florida teen suing social-media platforms over claims their design led to mental health issues dropped his lawsuit against Meta Platforms ahead of a trial slated to begin next week in Los Angeles.

Earlier this month, Roblox Corporation introduced Build, a mobile-first creation tab with integrated AI tools that let users generate playable game prototypes from text prompts directly in the core app, while linking work seamlessly with Roblox Studio and offering both free and paid tiers. At the same time, Roblox faces expanded securities class action lawsuits alleging prior misstatements about platform safety and the financial impact of its global age-verification rollout, underscoring how...

Novo Nordisk sues LLY over high-profile ads promoting Zepbound and Mounjaro, arguing newer clinical data changes the comparison as the GLP-1 rivalry intensifies.

By Jonathan Stempel NEW YORK, July 22 (Reuters) - A judge rejected Zelle's bid to dismiss a lawsuit by New York Attorney General Letitia James, who said the electronic payment platform's refusal to

A judge rejected Zelle's bid to dismiss a lawsuit by New York Attorney General Letitia James, who said the electronic payment platform's refusal to ‌adopt critical safety features enabled fraudsters to steal more than $1 billion from consumers. In a decision ‌late Monday, Justice Phaedra Perry-Bond of a New York state court in Manhattan said James sufficiently alleged that Zelle's parent Early Warning Services "prioritized ​accessibility, convenience, consumer adoption, and market dominance at the expense of consumer safety" in rushing the platform to market, despite objections from its banking partners. Early Warning Services is owned by seven large U.S. banks: Bank of America, Capital One, JPMorgan Chase, PNC, Truist, U.S. Bank and Wells Fargo.

Recall driven attention on Boston Scientific stock Boston Scientific (BSX) is back in focus after a series of voluntary recalls for its CRE and CRE Pro Wireguided gastrointestinal devices, tied to potential sterile pouch breaches across widely distributed product lots. With more than 81,000 units cited in individual recall notices and a worldwide distribution footprint, the situation brings product quality controls, potential regulatory implications and timing before the upcoming earnings...

Coinbase has settled a Freedom of Information Act lawsuit against the U.S. Securities ‌and Exchange Commission over records it sought ‌from the agency, the cryptocurrency exchange's chief legal officer, Paul Grewal, ​said in a Wall Street Journal op-ed on Wednesday. Grewal said the agency, which polices corporate record-keeping, had lost text messages between former Chair Gary Gensler and other ‌officials after a process ⁠the SEC said "automatically wiped" certain data.

By Daniel Wiessner July 22 (Reuters) - A novel lawsuit claiming that Meta Platforms relied on discriminatory AI tools to select employees for layoffs highlights the problems workers face in suing

Novo Nordisk’s lawsuit against Eli Lilly (LLY) over alleged misleading GLP-1 advertising has put fresh attention on Lilly’s stock and raised questions about how core obesity and diabetes franchises are being marketed. See our latest analysis for Eli Lilly. Against this legal backdrop, Eli Lilly’s 1-day share price return of 2.49% and 30-day share price return of 6.99% sit within a broader upswing, with a 52.46% 1-year total shareholder return and a very large 5-year total shareholder return...

Novo Nordisk is also demanding that Eli Lilly pull its ads and pay damages.